Literature DB >> 29047019

Challenges for nationwide vaccine delivery in African countries.

Mario Songane1.   

Abstract

Vaccines are very effective in providing individual and community (herd) immunity against a range of diseases. In addition to protection against a range of diseases, vaccines also have social and economic benefits. However, for vaccines to be effective, routine immunization programmes must be undertaken regularly to ensure individual and community protection. Nonetheless, in many countries in Africa, vaccination coverage is low because governments struggle to deliver vaccines to the most remote areas, thus contributing to constant outbreaks of various vaccine-preventable diseases. African governments fail to deliver vaccines to a significant percentage of the target population due to many issues in key areas such as policy setting, programme management and financing, supply chain, global vaccine market, research and development of vaccines. This review gives an overview of the causes of these issues and what is currently being done to address them. This review will discuss the role of philanthropic organisations such as the Bill and Melinda Gates Foundation and global partnerships such as the global alliance for vaccines and immunizations in the development, purchase and delivery of vaccines.

Keywords:  Africa; Delivery; Routine immunization; Supply chain; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 29047019     DOI: 10.1007/s10754-017-9229-5

Source DB:  PubMed          Journal:  Int J Health Econ Manag        ISSN: 2199-9031


  60 in total

1.  The potential global market size and public health value of an HIV-1 vaccine in a complex global market.

Authors:  Carol A Marzetta; Stephen S Lee; Sandra J Wrobel; Kanwarjit J Singh; Nina Russell; José Esparza
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

2.  Detection of yellow fever 17D genome in urine.

Authors:  Cristina Domingo; Sergio Yactayo; Edinam Agbenu; Maurice Demanou; Axel R Schulz; Katjana Daskalow; Matthias Niedrig
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

3.  Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.

Authors:  Kevin Outterson
Journal:  Yale J Health Policy Law Ethics       Date:  2005

Review 4.  Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries.

Authors:  Christopher L Karp; Deborah Lans; José Esparza; Eleanore B Edson; Katey E Owen; Christopher B Wilson; Penny M Heaton; Orin S Levine; Raja Rao
Journal:  Vaccine       Date:  2015-06-06       Impact factor: 3.641

5.  Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.

Authors:  S A Madhi; M Kirsten; C Louw; P Bos; S Aspinall; A Bouckenooghe; K M Neuzil; A D Steele
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

6.  Contagious diseases in the United States from 1888 to the present.

Authors:  Willem G van Panhuis; John Grefenstette; Su Yon Jung; Nian Shong Chok; Anne Cross; Heather Eng; Bruce Y Lee; Vladimir Zadorozhny; Shawn Brown; Derek Cummings; Donald S Burke
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

7.  Re-designing the Mozambique vaccine supply chain to improve access to vaccines.

Authors:  Bruce Y Lee; Leila A Haidari; Wendy Prosser; Diana L Connor; Ruth Bechtel; Amelia Dipuve; Hidayat Kassim; Balbina Khanlawia; Shawn T Brown
Journal:  Vaccine       Date:  2016-08-26       Impact factor: 3.641

8.  The Meningitis Vaccine Project.

Authors:  F Marc LaForce; Kader Konde; Simonetta Viviani; Marie-Pierre Préziosi
Journal:  Vaccine       Date:  2007-05-07       Impact factor: 3.641

9.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

10.  Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad.

Authors:  Patrick Lydon; Simona Zipursky; Carole Tevi-Benissan; Mamoudou Harouna Djingarey; Placide Gbedonou; Brahim Oumar Youssouf; Michel Zaffran
Journal:  Bull World Health Organ       Date:  2013-11-04       Impact factor: 9.408

View more
  7 in total

1.  Visibility and Analytics Network (VAN) approach to improve immunization supply chain and management performance system in Pakistan.

Authors:  Arshad Altaf; Anees Siddiqui; Agha Muhammad Ashfaq; Asm Shahabuddin
Journal:  J Glob Health       Date:  2021-03-07       Impact factor: 4.413

2.  Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.

Authors:  Isah Mohammed Bello; Emmaculate Lebo; Messeret Eshetu Shibeshi; Godwin Ubong Akpan; Jethro Chakauya; Balcha Girma Masresha; Fussum Daniel
Journal:  Pan Afr Med J       Date:  2021-02-12

3.  Molecular diagnostics of Salmonella and Campylobacter in human/animal fecal samples remain feasible after long-term sample storage without specific requirements.

Authors:  C B Harder; S Persson; J Christensen; A Ljubic; E M Nielsen; J Hoorfar
Journal:  AIMS Microbiol       Date:  2021-10-14

4.  The level and determinants of COVID-19 vaccine acceptance in Ghana.

Authors:  Grace Adjei Okai; Gordon Abekah-Nkrumah
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

5.  Optimized supply chain model reduces health system costs in DRC.

Authors:  Dorothy Thomas; Eomba Motomoke; Jessica Crawford; Olivier Defawe; Archimede Makaya; Jean Willy Ngwato; Joel Bompongo; Jose Monzembela; Gabriella Ailstock; Emily Bancroft; Bvudzai Magadzire; Dominique Baabo; Noel Watson
Journal:  Vaccine       Date:  2021-06-12       Impact factor: 3.641

6.  Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response time.

Authors:  Claudia E Vickers; Paul S Freemont
Journal:  Nat Commun       Date:  2022-01-21       Impact factor: 14.919

7.  Implementing epidemic intelligence in the WHO African region for early detection and response to acute public health events.

Authors:  George Sie Williams; Benido Impouma; Franck Mboussou; Theresa Min-Hyung Lee; Opeayo Ogundiran; Charles Okot; Tatiana Metcalf; Mary Stephen; Senait Tekeste Fekadu; Caitlin M Wolfe; Bridget Farham; Cristina Hofer; Bertil Wicht; Claudia Codeço Tores; Antoine Flahault; Olivia Keiser
Journal:  Epidemiol Infect       Date:  2021-05-14       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.